• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Yokoyama Keitaro  横山 啓太郎

ORCIDConnect your ORCID iD *help
… Alternative Names

YOKOYAMA Keitaro  横山 啓太郎

横山 啓太郎  ヨコヤマ ケイタロウ

Less
Researcher Number 70211654
Other IDs
Affiliation (Current) 2025: 東京慈恵会医科大学, 医学部, 教授
Affiliation (based on the past Project Information) *help 2018 – 2021: 東京慈恵会医科大学, 医学部, 教授
2017: 東京慈恵会医科大学, 医学部, 准教授
2011 – 2015: 東京慈恵会医科大学, 医学部, 准教授
2009 – 2010: Jikei University School of Medicine, 医学部, 講師
1993: 東京慈恵会医科大学, 医学部, 助手
Review Section/Research Field
Principal Investigator
Kidney internal medicine
Except Principal Investigator
Kidney internal medicine
Keywords
Principal Investigator
Vitamin D / resistin / リン代謝 / ビタミンD / 糖代謝異常 / ミネラル代謝 / 筋肉量 / 鉄代謝 / 糖代謝 / 糖・エネルギー代謝 … More / ミネラル代謝異常 / 慢性腎臓病 / ビタミンD受容体遺伝子 / 糖尿病性腎症 / carbohydrate metabolism / Carbohydrate Metabolism / CKD-MBD / 糖尿病腎症 / インスリン抵抗性 / 糖尿病 / リン / FGF23 / 心筋L型Ca^<2+>チャネル / 遺伝子多型 / モデルマウス / Klotho / 副甲状腺ホルモン / Ca^<2+>チャネル / 二次性副甲状腺機能亢進症 … More
Except Principal Investigator
FGS / ICAM-1 / TNF-alpha / IL-6 / IL-1 / カイロミクロンレムナント Less
  • Research Projects

    (4 results)
  • Research Products

    (47 results)
  • Co-Researchers

    (5 People)
  •  The relation between mineral and glucose metabolismPrincipal Investigator

    • Principal Investigator
      Yokoyama Keitaro
    • Project Period (FY)
      2017 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Kidney internal medicine
    • Research Institution
      Jikei University School of Medicine
  •  The effects of mineral metabolism on the progression of DM nephropathyPrincipal Investigator

    • Principal Investigator
      YOKOYAMA KEITARO
    • Project Period (FY)
      2012 – 2015
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Kidney internal medicine
    • Research Institution
      Jikei University School of Medicine
  •  Involvement of L-type calcium channels in high extracellular calcium-induced increase in cytoplasmic calcium concentration in parathyroid cells isolated from the patients with secondary hyperparathyroidism.Principal Investigator

    • Principal Investigator
      YOKOYAMA Keitaro
    • Project Period (FY)
      2009 – 2011
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Kidney internal medicine
    • Research Institution
      Jikei University School of Medicine
  •  腎糸球体硬化病変の発症・進展における高レムナント血症の関与についての研究

    • Principal Investigator
      酒井 聡一
    • Project Period (FY)
      1993
    • Research Category
      Grant-in-Aid for General Scientific Research (C)
    • Research Field
      Kidney internal medicine
    • Research Institution
      Jikei University School of Medicine

All 2022 2021 2019 2018 2016 2015 2014 2013 2012 2011 2010 2009 Other

All Journal Article Presentation

  • [Journal Article] Safety and effectiveness of ferric citrate hydrate in serum phosphorus management of patients with chronic kidney disease: a long-term, real-world, observational, post-marketing surveillance study2022

    • Author(s)
      Yokoyama Keitaro、Hashimoto Teruo、Okuda Yuri、Matsumoto Yu、Ito Kyoko、Yamada Ryoichi、Susai Hiroyuki、Nishino Noriaki
    • Journal Title

      Clinical and Experimental Nephrology

      Volume: - Issue: 7 Pages: 688-699

    • DOI

      10.1007/s10157-022-02204-1

    • Data Source
      KAKENHI-PROJECT-17K09740
  • [Journal Article] Ferric citrate hydrate is associated with a reduced cost of drugs and a smaller change in red blood cell distribution width2022

    • Author(s)
      Ito Kyoko、Yokoyama Keitaro、Nakayama Masaaki、Fukagawa Masafumi、Hirakata Hideki
    • Journal Title

      Scientific Reports

      Volume: 12 Issue: 1

    • DOI

      10.1038/s41598-022-06261-0

    • Data Source
      KAKENHI-PROJECT-17K09740
  • [Journal Article] Safety and efficacy of etelcalcetide, an intravenous calcimimetic, for up to 52 weeks in hemodialysis patients with secondary hyperparathyroidism: results of a post-marketing surveillance in Japan2021

    • Author(s)
      Keitaro Yokoyama , Masafumi Fukagawa , Takashi Shigematsu , Takashi Akiba , Ken Yoshikawa , Akira Tsuchiya , Misato Kuwabara , Tadao Akizawa
    • Journal Title

      Clin Exp Nephrol .

      Volume: 25 Issue: 1 Pages: 66-79

    • DOI

      10.1007/s10157-020-01936-2

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17K09740
  • [Journal Article] Association of fibroblast growth factor 23 and α-klotho in hemodialysis patients during administration of ferric citrate hydrate: post hoc analysis of ASTRIO study2021

    • Author(s)
      Ito Kyoko、Yokoyama Keitaro、Nakayama Masaaki、Fukagawa Masafumi、Hirakata Hideki
    • Journal Title

      BMC Nephrology

      Volume: 22 Issue: 1

    • DOI

      10.1186/s12882-021-02575-9

    • Data Source
      KAKENHI-PROJECT-17K09740
  • [Journal Article] Randomised clinical trial of ferric citrate hydrate on anaemia management in haemodialysis patients with hyperphosphataemia: ASTRIO study.2019

    • Author(s)
      Yokoyama K, Fukagawa M, Akiba T, Nakayama M, Ito K, Hanaki K, Wolf M, Hirakata H.
    • Journal Title

      Sci Rep.

      Volume: 9 Issue: 1 Pages: 8877-8877

    • DOI

      10.1038/s41598-019-45335-4

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K09740, KAKENHI-PROJECT-16K09622
  • [Journal Article] Long-Term Efficacy and Safety of Evocalcet in Japanese Patients with Secondary Hyperparathyroidism Receiving Hemodialysis.2019

    • Author(s)
      Yokoyama K, Shimazaki R, Fukagawa M, Akizawa T; Evocalcet Study Group.
    • Journal Title

      Sci Rep.

      Volume: 9 Issue: 1 Pages: 6410-6410

    • DOI

      10.1038/s41598-019-42017-z

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17K09740
  • [Journal Article] Association between resistin and fibroblast growth factor 23 in patients with type 2 diabetes mellitus.2018

    • Author(s)
      Nakashima A, Yokoyama K, Kawanami D, Ohkido I, Urashima M, Utsunomiya K, Yokoo T.
    • Journal Title

      Sci Rep.

      Volume: 18 Issue: 1 Pages: 139999-139999

    • DOI

      10.1038/s41598-018-32432-z

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17K09740, KAKENHI-PROJECT-18K16012
  • [Journal Article] Frequent monitoring of mineral metabolism in hemodialysis patients with secondary hyperparathyroidism: associations with achievement of treatment goals and with adjustments in therapy.2016

    • Author(s)
      Yokoyama K, Kurita N, Fukuma S, Akizawa T, Fukagawa M, Onishi Y, Kurokawa K, Fukuhara S.
    • Journal Title

      Nephrol Dial Transplant.

      Volume: in press Pages: gfw020-gfw020

    • DOI

      10.1093/ndt/gfw020

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-24591215, KAKENHI-PROJECT-25461257
  • [Journal Article] The value of ferric citrate, an iron-containing phosphate binder, might be different between Japan and the United States.2015

    • Author(s)
      Yokoyama K, Maruyama Y, Ohkido I, Yokoo T.
    • Journal Title

      Kidney Int.

      Volume: 87 Issue: 5 Pages: 1074-1075

    • DOI

      10.1038/ki.2015.45

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-24591215
  • [Journal Article] Does bone structure accurately reflect serum FGF23 levels in patients with chronic kidney disease?2015

    • Author(s)
      Yokoyama K, Nakashima A, Maruyama Y, Ohkido I, Yokoo T.
    • Journal Title

      Kidney Int.

      Volume: 88 Issue: 3 Pages: 640-640

    • DOI

      10.1038/ki.2015.206

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-24591215
  • [Journal Article] Chest X-ray may serve as a screening examination for coronary artery calcification in dialysis patients.2014

    • Author(s)
      Watanabe K, Yokoyama K, Yoshida H, Tanno Y, Ohkido I, Yokoo T.
    • Journal Title

      Kidney Int.

      Volume: 85 Pages: 710-710

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24591215
  • [Journal Article] A randomized trial of JTT-751 versus sevelamer hydrochloride in patients on hemodialysis.2014

    • Author(s)
      Yokoyama K, Akiba T, Fukagawa M, Nakayama M, Sawada K, Kumagai Y, Chertow GM, Hirakata H.
    • Journal Title

      Nephrol Dial Transplant.

      Volume: 29 Issue: 5 Pages: 1053-60

    • DOI

      10.1093/ndt/gft483

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24591215
  • [Journal Article] Chest X-ray may serve as a screening examination for coronary artery calcification in dialysis patients.2014

    • Author(s)
      Watanabe K, Yokoyama K, Yoshida H, Tanno Y, Ohkido I, Yokoo T
    • Journal Title

      Kidney Internatinal

      Volume: 85 Issue: 3 Pages: 710-710

    • DOI

      10.1038/ki.2013.509

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24591215
  • [Journal Article] JTT-751 for treatment of patients with hyperphosphatemia on peritoneal dialysis.2014

    • Author(s)
      Yokoyama K, Akiba T, Fukagawa M, Nakayama M, Hirakata H.
    • Journal Title

      Nephron Clin Pract.

      Volume: 128 Issue: 1-2 Pages: 135-40

    • DOI

      10.1159/000366482

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24591215
  • [Journal Article] A higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan.2014

    • Author(s)
      Maruyama Y, Taniguchi M, Kazama JJ, Yokoyama K, Hosoya T, Yokoo T, Shigematsu T, Iseki K, Tsubakihara Y.
    • Journal Title

      Nephrol Dial Transplant.

      Volume: Epub ahead of print Issue: 8 Pages: 1-6

    • DOI

      10.1093/ndt/gfu055

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24591215
  • [Journal Article] Long-term safety and efficacy of a novel iron-containing phosphate binder, JTT-751, in patients receiving hemodialysis.2014

    • Author(s)
      Yokoyama K, Akiba T, Fukagawa M, Nakayama M, Sawada K, Kumagai Y, Chertow GM, Hirakata H
    • Journal Title

      Journal of Renal Nutrition

      Volume: 24 Issue: 4 Pages: 261-267

    • DOI

      10.1053/j.jrn.2014.03.006

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24591215
  • [Journal Article] Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKD.2014

    • Author(s)
      Yokoyama K, Hirakata H, Akiba T, Fukagawa M, Nakayama M, Sawada K, Kumagai Y, Block GA.
    • Journal Title

      Clin J Am Soc Nephrol.

      Volume: 9 Issue: 3 Pages: 543-52

    • DOI

      10.2215/cjn.05170513

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24591215
  • [Journal Article] Kidney Int.2013

    • Author(s)
      Yokoyama K, Taniguchi M, Fukagawa M
    • Journal Title

      Kidney Int.

      Volume: Supplements 3 Pages: 451-456

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24591215
  • [Journal Article] Serum solubleα-Klotho in hemodialysis patients2012

    • Author(s)
      Yokoyama K, Imura A, Ohkido I, Maruyama Y, Yamazaki Y, Hasegawa H, Urae J, Sekino H, Nabeshima Y, Hosoya T
    • Journal Title

      Clin Nephrol

      Volume: (in press)

    • Data Source
      KAKENHI-PROJECT-21591063
  • [Journal Article] Serum soluble α-Klotho in hemodialysis patients2012

    • Author(s)
      Yokoyama K, Imura A, Ohkido I, Nabeshima Y, Hosoya T
    • Journal Title

      Clin Nephrol

      Volume: (in press)

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21591063
  • [Journal Article] Interactions between serum vitamin D levels and vitamin D receptor gene FokI polymorphisms for renal function in patients with type 2 diabetes2012

    • Author(s)
      Yokoyama K, Nakashima A, Urashima M, Utsunomiya K, Hosoya T.
    • Journal Title

      PLoS One.

      Volume: 7

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24591215
  • [Journal Article] Decrease of serum sphingosine-1-phosphate levels in hemodialysis patients with secondary hyperparathyroidism treated with cinacalcet.2012

    • Author(s)
      Yokoyama K, Ohkido I, Iwamoto T, Ishida M, Urashima M, Hosoya T.
    • Journal Title

      Clin Nephrol.

      Volume: 78 Pages: 85-6

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24591215
  • [Journal Article] Cinacalcet for hemodialyzed patients with or without a high PTH level to control serum calcium and phosphorus: ECO (evaluation of cinacalcet HCl outcome) study.2012

    • Author(s)
      Yokoyama K, Ohkido I, Ishida M, Hashimoto H, Urae J, Sekino H
    • Journal Title

      Clin Nephrol.

      Volume: 78 Pages: 87-93

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24591215
  • [Journal Article] Effect of oral JTT-751 (ferric citrate) on hyperphosphatemia in hemodialysis patients: results of a randomized, double-blind, placebo-controlled trial.2012

    • Author(s)
      Yokoyama K, Hirakata H, Akiba T, Sawada K, Kumagai Y.
    • Journal Title

      Am J Nephrol

      Volume: 36 Issue: 5 Pages: 478-87

    • DOI

      10.1159/000344008

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24591215
  • [Journal Article] Guidelines and medication compliance.2012

    • Author(s)
      Yokoyama K, Tanno Y, Ohkido I, Hosoya T.
    • Journal Title

      Kidney Int.

      Volume: 81 Pages: 595-595

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24591215
  • [Journal Article] L-type voltage-dependent calcium channel alpha subunit 1C is a novel candidate gene associated with secondary hyperparathyroidism : an application of haplotype-based analysis for multiple linked single-nucleotide polymorphisms.2010

    • Author(s)
      Yokoyama K, Urashima M, Ohkido I, Kono T, Yoshida T, Muramatsu M, Niu T, Hosoya T
    • Journal Title

      Nephron Clin Pract

      Volume: 115(4)

    • Data Source
      KAKENHI-PROJECT-21591063
  • [Journal Article] Alpha-Klotho(α-Kl) expressions remained in the parathyroid glands of patients with secondary hyperparathyroidism2010

    • Author(s)
      Ohkido I, Yokoyama K, Kagami S, Hosoya T
    • Journal Title

      Nephrol Dial Transplant

    • Data Source
      KAKENHI-PROJECT-21591063
  • [Journal Article] Alpha-Klotho (α-K1) expressions remained in the parathyroid glands of patients with secondary hyperparathyroidism.2010

    • Author(s)
      Ohkido I, Yokoyama K, Kagami S, Hosoya T.
    • Journal Title

      Nephrol Dial Transplant.

      Volume: 25 Pages: 1008-1009

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21591063
  • [Journal Article] Should the targeted value of the phosphate be reviewed lower to normal range from the viewpoint of vascular calcification2010

    • Author(s)
      Yokoyama K, Yoshida H, Maruyama Y, Ozaki A, Yamamoto H, Hosoya T
    • Journal Title

      Kidney Int.

      Volume: 77(10) Pages: 928-928

    • Data Source
      KAKENHI-PROJECT-21591063
  • [Journal Article] The hypothesis that bone turnover influenced FGF23 secretion2010

    • Author(s)
      Ohkido I, Yokoyama K, Kagami S, Hosoya T
    • Journal Title

      Kidney Int

      Volume: 77(8) Pages: 743-743

    • Data Source
      KAKENHI-PROJECT-21591063
  • [Journal Article] L-type voltage-dependent calcium channel alpha subunit 1C is a novel candidate gene associated with secondary hyperparat hyroidisln : an application of haplotype-based analysis for multiple linked single-nucleotide polymorphisms2010

    • Author(s)
      Keitaro Yokoyama
    • Journal Title

      Nephron Clin Pract. (In press)

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21591063
  • [Journal Article] Dihydropyridine- and voltage-sensitive Ca^<2+> entry in human parathyroid cells.2009

    • Author(s)
      Keitaro Yokoyama
    • Journal Title

      Exp Physiol. 94

      Pages: 847-855

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21591063
  • [Journal Article] Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional Study.

    • Author(s)
      Nakashima A, Ohkido I, Yokoyama K, Mafune A, Urashima M, Yokoo T.
    • Journal Title

      PLoS One.

      Volume: 10 Issue: 11 Pages: e0143656-e0143656

    • DOI

      10.1371/journal.pone.0143656

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-24591215
  • [Presentation] Ferric Citrate Hydrate on Anemia Management in Hyperphosphatemia Hemodialysis Patients with or without Diabetes: ASTRIO Study, Supplementary Analysis2019

    • Author(s)
      Yokoyama K, Fukagawa M, Nakayama M, Ito K, Hirakata H.
    • Organizer
      米国腎臓学会
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K09740
  • [Presentation] Effect of Ferric Citrate Hydrate on Fibroblast Growth Factor 23 and Serum Alpha-Klotho in Hemodialysis Patients with Hyperphosphatemia, under Serum Phosphate Level was maintained: ASTRIO Study, Supplementary Analysis2018

    • Author(s)
      YokoyamaK, Fukagawa M, Nakayama M, Hanaki K, Ito K, Hirakata H
    • Organizer
      米国腎臓学会
    • Data Source
      KAKENHI-PROJECT-17K09740
  • [Presentation] 包括的なリン管理の実際2015

    • Author(s)
      横山啓太郎
    • Organizer
      第60回日本透析医学会学術集会・総会
    • Place of Presentation
      横浜
    • Year and Date
      2015-06-26
    • Invited
    • Data Source
      KAKENHI-PROJECT-24591215
  • [Presentation] Paradigm Shift for CKD-MBD2015

    • Author(s)
      Yokoyama K
    • Organizer
      16th Asian Nephrology conference
    • Place of Presentation
      Kaohsiung Taiwan
    • Year and Date
      2015-04-24
    • Invited / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-24591215
  • [Presentation] Decreasing ESA dosage can be a factor of the increase in ferritin under the administration of ferric citrate with improving ESA resistance index.2015

    • Author(s)
      Yokoyama K, Akiba T, Fukagawa M, Nakayama M, Hirakata H.
    • Organizer
      ASN Kidney Week - 2015
    • Place of Presentation
      SanDiego U.S.A
    • Year and Date
      2015-11-03
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-24591215
  • [Presentation] Clinical Practice Guideline for CKD-MBD2013

    • Author(s)
      Yokoyama K.
    • Organizer
      The 7th China-Korea-Japan Nephrology Conference2013 March
    • Place of Presentation
      Soul. Korea
    • Invited
    • Data Source
      KAKENHI-PROJECT-24591215
  • [Presentation] Differential Associations of 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D with Impaired Renal Function in Patients with Diabetes2012

    • Author(s)
      Yokoyama K, Nakashima A, Urashima M, Ohkido I, Hosoya T.
    • Organizer
      45th Annual Meeting of American Society of Nephrology.
    • Place of Presentation
      SanDiego. U.S.A.
    • Data Source
      KAKENHI-PROJECT-24591215
  • [Presentation] Decrease of serum sphingosine-1-phosphate levels in hemodialysis patients with secondary hyperparathyroidism treated with Cinacalcet2011

    • Author(s)
      Yokoyama K, Ohkido I, Iwamoto T, Ishida M, Hosoya T
    • Place of Presentation
      Philadelphia
    • Year and Date
      2011-12-12
    • Data Source
      KAKENHI-PROJECT-21591063
  • [Presentation] Mice fed adenine-containing diet is optimal model of tubulointerstitial damage with renal dysfunction2011

    • Author(s)
      Yamamoto I, Yokoyama K, Ohkido I et. al
    • Organizer
      44th Annual Meeting of American Society of Nephrology
    • Place of Presentation
      Philadelphia
    • Year and Date
      2011-12-10
    • Data Source
      KAKENHI-PROJECT-21591063
  • [Presentation] Vitamin D analogues with TGF-β signal inhibition property ameliorates renal fibrotic lesions in UUO mice2009

    • Author(s)
      YokoyamaK, Ohkido I, Ito I, Murayama A, Yanagisawa J, Hosoya T
    • Organizer
      42th Annual Meeting of American Society of Nephrology
    • Place of Presentation
      San Diego, California
    • Year and Date
      2009-10-31
    • Data Source
      KAKENHI-PROJECT-21591063
  • [Presentation] リン吸着薬

    • Author(s)
      横山啓太郎
    • Organizer
      第57回日本透析医学会
    • Place of Presentation
      福岡
    • Invited
    • Data Source
      KAKENHI-PROJECT-24591215
  • [Presentation] The Effect of JTT-751 (Ferric Citrate Hydrate) on Phosphorus and FGF-23 in Chronic Kidney Disease

    • Author(s)
      Yokoyama K, Hirakata H, Akiba T, Fukagawa M, Nakayama M, Sawada K, Kumagai Y, Block GA.
    • Organizer
      46th Annual Meeting of American Society of Nephrology.
    • Place of Presentation
      Atlanta, GA
    • Data Source
      KAKENHI-PROJECT-24591215
  • [Presentation] 保存期慢性腎臓病患者のリン管理.

    • Author(s)
      横山啓太郎
    • Organizer
      第44回日本腎臓学会東部学術大会
    • Place of Presentation
      東京
    • Year and Date
      2014-10-24 – 2014-10-25
    • Invited
    • Data Source
      KAKENHI-PROJECT-24591215
  • [Presentation] 慢性腎臓病における骨・ミネラル代謝異常

    • Author(s)
      横山啓太郎
    • Organizer
      第57回日本腎臓学会学術総会
    • Place of Presentation
      横浜
    • Year and Date
      2014-07-04 – 2014-07-06
    • Invited
    • Data Source
      KAKENHI-PROJECT-24591215
  • 1.  URASHIMA Mituyoshi (80203602)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 5 results
  • 2.  OHKIDO Ichiro (40372966)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 9 results
  • 3.  酒井 聡一 (10056806)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 4.  川村 哲也 (20161367)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 5.  中島 章雄 (20624688)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi